AI therapeutics company built on causal biology, today announced the publication of research in Nature Communications validating its POSH (Pooled Optical Screening in Human cells) platform. The study ...
Success demonstrates the power of EMMI, Terray’s proprietary AI platform integrated with its rapidly expanding 13B+ target-ligand binding database and highly automated lab LOS ANGELES--(BUSINESS WIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback